Boston Heart Diagnostics

Boston Heart Diagnostics is a clinical laboratory that provides comprehensive cardiovascular and cardiometabolic testing to help patients and providers understand disease risk with precision. Founded in 2007 and headquartered in Framingham, Massachusetts, the company operates a CAP-accredited, CLIA-certified laboratory that specializes in advanced diagnostic techniques including gel electrophoresis, gas chromatography, genetic testing, and high-performance liquid chromatography. Their core offering moves beyond standard lipid panels to measure biomarkers like lipoprotein(a), lipid particle numbers, inflammation markers, and HDL subpopulations that provide a more complete picture of cardiovascular risk.

Boston Heart's approach integrates three phases: Characterize (using novel diagnostics to produce color-coded reports with clinical interpretations), Individualize (translating test results into actionable steps tailored to each patient), and Engage (providing personalized nutrition and lifestyle plans based on lab results and individual food preferences). This integrated model aims to improve patient understanding, health literacy, and adherence to treatment plans. The company offers both routine blood work assessments and exclusive test panels such as CVMap, the HDL Map test, and the Cholesterol Balance test, along with specialized panels for prediabetes, thyroid disorders, nutrient deficiencies, and hormone health.

Boston Heart serves both patients seeking direct testing and healthcare providers looking to offer more precise risk stratification. The company maintains a Scientific Advisory Board of recognized experts in lipoprotein testing, insulin resistance, diabetes, obesity, nutrition, and lifestyle medicine. All laboratory testing is performed in-house with state-of-the-art equipment operated by highly qualified staff to ensure accurate and consistent results.